Literature DB >> 11840200

HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls.

D de Juan1, A Reta, A Castiella, J Pozueta, A Prada, E Cuadrado.   

Abstract

C282Y/C282Y genotype is the prevalent genotype in Hereditary Haemochromatosis (HH), however, other genotypes have been associated with the disease. The objective of our study was to analyse the frequency of the three main mutations of HFE gene in HH patients and controls from the Basque population with differential genetic characteristics. Thirty five HH patients and 116 controls were screened for C282Y, H63D and S65C mutations using a PCR-RFLP technique. The association of HLA-A and-B alleles and HFE mutations was also studied in Basque controls. The frequency of C282Y homozygotes in the group of patients was only 57%. The rest of the patients presented heterogeneous genotypes, including compound heterozygotes: 11% of them were C282Y/H63D; and 2.85% were H63D/S65C. H63D or S65C heterozygotes had a frequency of 11% and 2.85 respectively and 5.71% patients lacked any mutation The high frequency of H63D in the healthy Basque population is confirmed in this study. A considerable incidence of S65C is observed either in controls and in HH (3%) or in iron overloaded patients. The peculiar genetic characteristics of Basques could explain the heterogeneity of genotypes in HH patients of this group. Further studies should be carried out to confirm these findings although the implication of other genetic or external factors in the development of HH is suggested.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11840200     DOI: 10.1038/sj.ejhg.5200731

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

1.  Gender and plasma iron biomarkers, but not HFE gene mutations, increase the risk of colorectal cancer and polyps.

Authors:  Agustin Castiella; Fernando Múgica; Eva Zapata; Leire Zubiaurre; Arantxa Iribarren; M Dolores de Juan; Luis Alzate; Ines Gil; Gregorio Urdapilleta; Pedro Otazua; José Ignacio Emparanza
Journal:  Tumour Biol       Date:  2015-04-09

2.  Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients.

Authors:  C A McCune; D Ravine; K Carter; H A Jackson; D Hutton; J Hedderich; M Krawczak; M Worwood
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

3.  Iron overload and HFE mutations: are they relevant in cryptogenic cirrhosis?

Authors:  Agustin Castiella
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

4.  The role of HFE mutations on iron metabolism in beta-thalassemia carriers.

Authors:  Rute Martins; Isabel Picanço; Aidil Fonseca; Lídia Ferreira; Odete Rodrigues; Marília Coelho; Teresa Seixas; Armandina Miranda; Baltazar Nunes; Luciana Costa; Luísa Romão; Paula Faustino
Journal:  J Hum Genet       Date:  2004-11-05       Impact factor: 3.172

5.  Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis.

Authors:  Shunji Tomatsu; Koji O Orii; Robert E Fleming; Christopher C Holden; Abdul Waheed; Robert S Britton; Monica A Gutierrez; Susana Velez-Castrillon; Bruce R Bacon; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

6.  HLA haplotypes associated with hemochromatosis mutations in the Spanish population.

Authors:  Arantza Pacho; Esther Mancebo; Manuel J del Rey; Maria J Castro; Desamparados Oliver; Miguel García-Berciano; Luis González; Pablo Morales
Journal:  BMC Med Genet       Date:  2004-10-21       Impact factor: 2.103

7.  Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.

Authors:  Marko Cukjati; Tomaz Vaupotic; Ruth Rupreht; Vladka Curin-Serbec
Journal:  BMC Med Genet       Date:  2007-11-23       Impact factor: 2.103

8.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.